These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28645175)

  • 1. Perturbation to Cholesterol at the Neuromuscular Junction Confers Botulinum Neurotoxin A Sensitivity to Neonatal Mice.
    Thyagarajan B; Potian JG; McArdle JJ; Baskaran P
    Toxicol Sci; 2017 Sep; 159(1):179-188. PubMed ID: 28645175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.
    Baskaran P; Lehmann TE; Topchiy E; Thirunavukkarasu N; Cai S; Singh BR; Deshpande S; Thyagarajan B
    Toxicon; 2013 Sep; 72():71-80. PubMed ID: 23810945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction.
    Baskaran P; Thyagarajan B
    Muscle Nerve; 2014 Aug; 50(2):206-15. PubMed ID: 24218344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a.
    Thyagarajan B; Krivitskaya N; Potian JG; Hognason K; Garcia CC; McArdle JJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):361-71. PubMed ID: 19654265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.
    Thyagarajan B; Potian JG; Garcia CC; Hognason K; Capková K; Moe ST; Jacobson AR; Janda KD; McArdle JJ
    Neuropharmacology; 2010 Jun; 58(8):1189-98. PubMed ID: 20211192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
    Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice.
    Fujikawa R; Muroi Y; Unno T; Ishii T
    J Toxicol Sci; 2010 Dec; 35(6):795-805. PubMed ID: 21139329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms.
    Bradford AB; Machamer JB; Russo TM; McNutt PM
    Toxicol Appl Pharmacol; 2018 Feb; 341():77-86. PubMed ID: 29366638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
    Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
    Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
    PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black tea extract, thearubigin fraction, counteract the effects of botulinum neurotoxins in mice.
    Satoh E; Ishii T; Shimizu Y; Sawamura S; Nishimura M
    Br J Pharmacol; 2001 Feb; 132(4):797-8. PubMed ID: 11181419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between heavy metal chelators and botulinum neurotoxins at the mouse neuromuscular junction.
    Sheridan RE; Deshpande SS
    Toxicon; 1995 Apr; 33(4):539-49. PubMed ID: 7570639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin modulates acetylcholine release at the myoneural junction.
    Thyagarajan B; Potian JG; Baskaran P; McArdle JJ
    Eur J Pharmacol; 2014 Dec; 744():211-9. PubMed ID: 25446918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.
    Colasante C; Rossetto O; Morbiato L; Pirazzini M; Molgó J; Montecucco C
    Mol Neurobiol; 2013 Aug; 48(1):120-7. PubMed ID: 23471747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
    Cai BB; Francis J; Brin MF; Broide RS
    Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset dynamics of type A botulinum neurotoxin-induced paralysis.
    Lebeda FJ; Adler M; Erickson K; Chushak Y
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):251-67. PubMed ID: 18551355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
    Adler M; Keller JE; Sheridan RE; Deshpande SS
    Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
    Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
    J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
    J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.